<?xml version="1.0" encoding="UTF-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
  <title>Index Ventures News</title>
  <link rel="alternate" href="http://www.indexventures.com/"></link>
  <id>http://www.indexventures.com/</id>
  <updated>2012-01-31T15:57:37Z</updated>
  <author>
    <name>Index Ventures</name>
    <email>info@indexventures.com</email>
  </author>
<entry>
  <title>IBM Advances Mobile Capabilities with Acquisition of Worklight</title>
  <link rel="alternate" href="http://www.indexventures.com/news/index/news_id/319"></link>
  <updated>2012-01-31T15:57:37Z</updated>
  <id>319</id>
  <summary type="text">Acquisition Adds Leading Platform for Smartphones and Tablets to Comprehensive Mobile Portfolio ARMONK, NY - 31 Jan 2012: In a move that will help expand the enterprise mobile capabilities it offers to clients, IBM (NYSE: IBM) today...</summary>
</entry>
<entry>
  <title>ProFibrix US Phase II Study with FibrocapsTM Meets All Primary and Secondary Endpoints</title>
  <link rel="alternate" href="http://www.indexventures.com/news/index/news_id/318"></link>
  <updated>2012-01-09T08:43:12Z</updated>
  <id>318</id>
  <summary type="text">Jan. 5, 2012- LEIDEN, The Netherlands &amp;amp; Seattle--(BUSINESS WIRE)-- ProFibrix B.V., a leader in the development of innovative products for hemostasis, today announced that its U.S. multicenter Phase II clinical trial with Fibrocaps in...</summary>
</entry>
<entry>
  <title>Outbrain Raises $35 Million USD in Series D Funding; Led by Index Ventures</title>
  <link rel="alternate" href="http://www.indexventures.com/news/index/news_id/317"></link>
  <updated>2011-12-19T16:23:56Z</updated>
  <id>317</id>
  <summary type="text">NEW YORK - DEC. 14, 2011&amp;nbsp;Outbrain, the leading content discovery platform, today announced that it has closed its Series D round of funding of $35 million, bringing its total financing to $64 million. Index Ventures led the round with...</summary>
</entry>
<entry>
  <title>ProFibrix Phase II with FibrocapsTM Meets Primary Endpoint – On Track for Phase III in 2012 </title>
  <link rel="alternate" href="http://www.indexventures.com/news/index/news_id/316"></link>
  <updated>2011-12-15T13:59:40Z</updated>
  <id>316</id>
  <summary type="text">Leiden, The Netherlands and Seattle, WA, November 15, 2011 - ProFibrix B.V., a leader in the development of innovative products for hemostasis, today announced that its multicenter Phase II clinical trial with Fibrocaps in liver resection...</summary>
</entry>
<entry>
  <title>iZettle Rings Up €8.2 Million ($11.2 Million) In Series A Funding</title>
  <link rel="alternate" href="http://www.indexventures.com/news/index/news_id/315"></link>
  <updated>2011-10-19T15:18:08Z</updated>
  <id>315</id>
  <summary type="text">Stockholm - 19th of October 2011: iZettle, the social payments company, today announced it has received &amp;euro;8.2 million ($11.2 million) in Series A funding led by Index Ventures with co-investor Creandum and further investment from...</summary>
</entry>
<entry>
  <title>Red Hat To Acquire Gluster</title>
  <link rel="alternate" href="http://www.indexventures.com/news/index/news_id/314"></link>
  <updated>2011-10-04T15:39:24Z</updated>
  <id>314</id>
  <summary type="text">  Ushers in New Era of Software-Based Open Storage Platforms to Unify On-Premise and Cloud   Adds Scale-Out Management of Unstructured Data to Red Hat Portfolio with Gluster&amp;rsquo;s Disruptive Open Source Storage Solutions   Raleigh, NC...</summary>
</entry>
<entry>
  <title>Nature Biotechnology Podcast Interview with Francesco De Rubertis</title>
  <link rel="alternate" href="http://www.indexventures.com/news/index/news_id/313"></link>
  <updated>2011-10-03T12:53:15Z</updated>
  <id>313</id>
  <summary type="text">Brady Huggett of Nature Biotechnology with Francesco De Rubertis of Index Ventures and author of &amp;quot;Six secrets to success - how to build a sustainable biotech business&amp;quot; discussing practical advice and guidance, acquired from his...</summary>
</entry>
<entry>
  <title>Salesforce.com Acquires Assistly</title>
  <link rel="alternate" href="http://www.indexventures.com/news/index/news_id/312"></link>
  <updated>2011-09-22T11:46:28Z</updated>
  <id>312</id>
  <summary type="text">SAN FRANCISCO, Sept. 21, 2011 /PRNewswire/ -- Salesforce.com (NYSE:&amp;nbsp;&amp;nbsp;  CRM), the enterprise cloud computing company, today announced it has acquired Assistly, an instant customer-service help desk built for the cloud.Assistly...</summary>
</entry>
<entry>
  <title>ProFibrix Completes Enrollment of Phase II Studies</title>
  <link rel="alternate" href="http://www.indexventures.com/news/index/news_id/311"></link>
  <updated>2011-09-14T08:27:08Z</updated>
  <id>311</id>
  <summary type="text">ProFibrix B.V., a leader in the development of innovative products for hemostasis, today announced that it has completed patient enrollment in its two (U.S. and Dutch) prospective, randomized, controlled, multi-center Phase II studies with...</summary>
</entry>
<entry>
  <title>OZON.ru closes $100 million funding to support company growth</title>
  <link rel="alternate" href="http://www.indexventures.com/news/index/news_id/310"></link>
  <updated>2011-09-08T09:46:45Z</updated>
  <id>310</id>
  <summary type="text">OZON.ru, Russia's leading online retailer, has today announced that it has completed a $100 million funding round.&amp;nbsp; &amp;nbsp;The investor consortium, led by ru-Net Ltd, an existing investor in OZON.ru, also includes major Japanese online...</summary>
</entry>
</feed>
